Kinnov Therapeutics SAS - Company Review
Kinnov Therapeutics SAS - Company ReviewSummary
Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors are used in the treatment of arterial high blood pressurel; and antagonist of 5HT2 and 5HT1C receptors are used in the treatment of allergy. Kinnova’s preclinical research and development addiction include identifying the key receptors of addictions, selecting compounds inhibiting these receptors, developing a therapeutic composition for human and validating the concept on proper animal models. It partners with pharma company to conduct phase III studies for its pipeline product. Kinnov is headquartered in Orleans, France.
This comprehensive company report of Kinnov Therapeutics SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.